108 related articles for article (PubMed ID: 1461092)
1. A study of T1-weighted 31phosphorus MR-spectroscopy from patients with focal and diffuse liver disease.
Brinkmann G; Melchert UH
Magn Reson Imaging; 1992; 10(6):949-56. PubMed ID: 1461092
[TBL] [Abstract][Full Text] [Related]
2. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
3. [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].
Brinkmann G; Melchert UH; Lalk G; Heller M
Rofo; 1993 Nov; 159(5):412-8. PubMed ID: 8219133
[TBL] [Abstract][Full Text] [Related]
4. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases.
Brinkmann G; Melchert UH; Lalk G; Emde L; Link J; Muhle C; Steffens JC; Heller M
Invest Radiol; 1997 Feb; 32(2):100-4. PubMed ID: 9039582
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.
Sevastianova K; Hakkarainen A; Kotronen A; Cornér A; Arkkila P; Arola J; Westerbacka J; Bergholm R; Lundbom J; Lundbom N; Yki-Järvinen H
Radiology; 2010 Aug; 256(2):466-73. PubMed ID: 20656836
[TBL] [Abstract][Full Text] [Related]
6. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
[TBL] [Abstract][Full Text] [Related]
7. [In vivo 31-phosphorus magnetic resonance spectroscopy of liver diseases].
Brinkmann G; Melchert U; Förger K; Wunsch-Binder F; Heidemann H; Engemann R
Rofo; 1990 Aug; 153(2):204-8. PubMed ID: 2168078
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of functional severity on in vivo hepatic 31P-MRS in diffuse hepatic disease: comparative studies with 99mTc-GSA].
Matoba M; Tonami H; Yokota H; Higashi K; Yamamoto I
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jul; 60(8):439-44. PubMed ID: 10965750
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].
Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL
Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264
[TBL] [Abstract][Full Text] [Related]
10. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.
Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY
Gastroenterology; 1995 Mar; 108(3):776-88. PubMed ID: 7875480
[TBL] [Abstract][Full Text] [Related]
11. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
Lee JM; Kim CS; Youk JH; Lee MS
Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver].
Sun JZ; Wang ZK; Yu RS; Huang LS; Xu XF; Zhang MM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 39(2):150-6. PubMed ID: 20387242
[TBL] [Abstract][Full Text] [Related]
13. Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases.
Brinkmann G; Melchert UH; Muhle C; Brossmann J; Link J; Reuter M; Heller M
Eur Radiol; 1996; 6(1):62-5. PubMed ID: 8797952
[TBL] [Abstract][Full Text] [Related]
14. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
15. [Initial experiences with MR in liver tumors].
Uhlenbrock D; Börsch G; Beyer HK; Schmidt G
Rofo; 1985 Aug; 143(2):200-7. PubMed ID: 2992037
[TBL] [Abstract][Full Text] [Related]
16. In vivo P-31-MR-spectroscopy of focal hepatic lesions. Effectiveness of tumor detection in clinical practice and experimental studies of surface coil characteristics and localization technique.
Brinkmann G; Melchert UH; Emde L; Wolf H; Muhle C; Brossmann J; Reuter M; Heller M
Invest Radiol; 1995 Jan; 30(1):56-63. PubMed ID: 7759218
[TBL] [Abstract][Full Text] [Related]
17. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
[TBL] [Abstract][Full Text] [Related]
18. [Spectroscopic imaging of the human liver using 3D CSI: optimization and application in patients with metastatic uvea melanoma].
Beer M; Winkelmann V; Becker JC; Terheyden P; Stenzel M; Bröcker EB; Hahn D; Köstler H
Rofo; 2009 Jan; 181(1):60-6. PubMed ID: 19085691
[TBL] [Abstract][Full Text] [Related]
19. Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy.
Dixon RM; Angus PW; Rajagopalan B; Radda GK
Br J Cancer; 1991 Jun; 63(6):953-8. PubMed ID: 2069850
[TBL] [Abstract][Full Text] [Related]
20. [Clinical application of 31P MRS to malignant liver tumors--with an emphasis on evaluation of response to therapy].
Saeki M; Ashida H; Imamura K; Fukui A; Ishizuka K; Kuwabara M; Wakabayashi M; Ishikawa T; Iwabuchi S; Mizuguchi A
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun; 52(6):744-54. PubMed ID: 1322523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
